Ehab Atallah

Congestive heart failure is a rare event in patients receiving imatinib therapy

Ehab Atallah, Jean‐Bernard Durand, Hagop Kantarjian et al. · Blood · 2007 · 253 citations

Medicine, Cardiology, Internal Medicine +3

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117

Mikkael A. Sekeres, Megan Othus, Alan F. List et al. · Journal of Clinical Oncology · 2017 · 238 citations

Medicine, Oncology, Pharmacotherapy +15

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

Mark R. Litzow, Zhuoxin Sun, Ryan J. Mattison et al. · New England Journal of Medicine · 2024 · 215 citations · Full text

Medicine, Hematology, Oncology +16

Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial

Guillermo Garcia‐Manero, Pierre Fenaux, Aref Al‐Kali et al. · The Lancet Oncology · 2016 · 171 citations

Medicine, Pharmacotherapy, Clinical Pharmacology +6

Follow-up of patients with R/R <i>FLT3-</i>mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

Alexander E. Perl, Richard A. Larson, Nikolai A. Podoltsev et al. · Blood · 2022 · 137 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13